Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Managing personal information on a network
Method for using extended security system, extended security system and devices
Method of making a CIG target by cold spraying
Error protection for pipeline resources
Electronic device package and fabrication method thereof
Pre-sealing unit for wire-cut electric discharge machine
Minimizing mismatch during compensation
  Randomly Featured Patents
In-grade lighting fixture
Prefetch streaming buffer
Automatic frequency scanning radio receiver
Beverage container with straw
Immunoseparating strip
System and method for sending an emergency message selected from among multiple emergency message types from a wireless communications device
Electronic endoscope apparatus which superimposes signals on power supply
Container for perfume or the like
Light beam scanning pen, scan module for the device and method of utilization
Addressable speaker system